Russia’s Sputnik V Covid 19 vaccine approved in India for emergency use

New Delhi: The Subject Expert Committee (SEC) has given approval to the Russian Covid 19 vaccine Sputnik V for emergency use in India.

As per reports, the Drugs Controller General of India (DCGI)’s Subject Expert Committee (SEC) met on Monday to decide about approval of Sputnik V for Emergency Use in India.

It is to be noted that India has now faced the second wave of Coronavirus cases. Also, vaccine shortage has been witnessed recently.

In India, the Sputnik V will be manufactured by drug maker Dr Reddy’s Laboratories.

Also read: India to produce 300mn doses of Sputnik V vaccine in 2021: Report

In September 2020, Dr. Reddy’s had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and for its distribution rights in India. The company had conducted Phase 2 trials in India with 1,500 participants.

Dr Reddy’s Laboratories, the Hyderabad-based pharma major had applied for its emergency licensure on February 19. After Covishield and Covaxin, Sputnik V is the third coronavirus vaccine to be administered in India.

So far, more than six crore doses of corona vaccine have been administered in the country since the drive began on January 16 after the approval for ‘Covishield’ and ‘Covaxin’.

(With inputs from IANS)